These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1876284)

  • 41. Effect of dialyser composition and reuse on neutrophil count and elastase alpha-1 proteinase inhibitor complex formation.
    Donovan KL; Pacholok S; Phillips A; Humes JL; Coles GA; Williams JD
    Int J Artif Organs; 1992 Mar; 15(3):139-43. PubMed ID: 1521897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood-membrane interactions during haemodialysis with cellulose and synthetic membranes.
    Woffindin C; Hoenich NA
    Biomaterials; 1988 Jan; 9(1):53-7. PubMed ID: 3126842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis].
    Szepietowski T; el-Hayek A
    Polim Med; 1993; 23(3-4):43-54. PubMed ID: 8029157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low thrombogenicity of polyethylene glycol-grafted cellulose membranes does not influence heparin requirements in hemodialysis.
    Wright MJ; Woodrow G; Umpleby S; Hull S; Brownjohn AM; Turney JH
    Am J Kidney Dis; 1999 Jul; 34(1):36-42. PubMed ID: 10401013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet activation on hemodialysis: influence of dialysis membranes.
    Cases A; Reverter JC; Escolar G; Sanz C; Lopez-Pedret J; Revert L; Ordinas A
    Kidney Int Suppl; 1993 Jun; 41():S217-20. PubMed ID: 8320925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clearance of ceftriaxone during haemodialysis using cuprophane, haemophane and polysulfone dialysers.
    Gabutti L; Taminelli-Beltraminelli L; Marone C
    Eur J Clin Pharmacol; 1997; 53(2):123-6. PubMed ID: 9403283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adsorption and reactivity of human fibrinogen and immunoglobulin G on two types of hemodialysis membranes.
    Chuang HY; Sharpton TR; Mohammad SF
    Int J Artif Organs; 1983 Jul; 6(4):199-206. PubMed ID: 6629526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Choice of dialysis membrane does not influence the outcome of residual renal function in haemodialysis patients.
    Caramelo C; Alcázar R; Gallar P; Teruel JL; Velo M; Ortega O; Galera A; Da Silva M
    Nephrol Dial Transplant; 1994; 9(6):675-7. PubMed ID: 7970095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein catabolism in maintenance haemodialysis: the influence of the dialysis membrane.
    Gutierrez A
    Nephrol Dial Transplant; 1996; 11 Suppl 2():108-11. PubMed ID: 8804008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
    Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J
    Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of different dialyzer membranes on serum angiotensin-converting enzyme during hemodialysis.
    Docci D; Delvecchio C; Turci F; Baldrati L; Gollini C
    Int J Artif Organs; 1988 Jan; 11(1):28-32. PubMed ID: 2834297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemostatic disturbances induced by two hollow-fiber hemodialysis membranes.
    Reber G; Stoermann C; de Moerloose P; Ruedin P; Leski M
    Int J Artif Organs; 1992 May; 15(5):269-76. PubMed ID: 1601510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deviations in coagulation activation due to treatment with different haemodialysis membranes.
    Bartels PC; Schoorl M; Schoorl M; Nubé MJ
    Scand J Clin Lab Invest; 2003; 63(6):417-24. PubMed ID: 14594322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mediators of complement-independent granulocyte activation during haemodialysis: role of calcium, prostaglandins and leukotrienes.
    Böhler J; Donauer J; Birmelin M; Schollmeyer PJ; Hörl WH
    Nephrol Dial Transplant; 1993; 8(12):1359-65. PubMed ID: 8159305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Haemodialyser biocompatibility and erythrocyte structure and function.
    Martos MR; Hendry BM; Rodríguez-Puyol M; Dwight J; Díez-Marqués ML; Rodríguez-Puyol D
    Clin Chim Acta; 1997 Sep; 265(2):235-46. PubMed ID: 9385465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biocompatibility of hemodialysis using cuprophane membranes.
    Rommes JH; Sangster B; Borst C; Daha MR; van Heijst NP
    Vet Hum Toxicol; 1987 Aug; 29(4):293-9. PubMed ID: 3629907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Minimodule dialyser for quantitative ex vivo evaluation of membrane haemocompatibility in humans: comparison of acrylonitrile copolymer, cuprophan and polysulphone hollow fibres.
    Mulvihill J; Cazenave JP; Mazzucotelli JP; Crost T; Collier C; Renaux JL; Pusineri C
    Biomaterials; 1992; 13(8):527-36. PubMed ID: 1633226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of dialyzer membranes on beta-2 microglobulin production in Thai hemodialysis patients.
    Domrongkitchaiporn S; Chuncharunee S; Archararit N; Atamasirikul K; Vanichakarn S
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S138-43. PubMed ID: 9347661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro blood compatibility evaluation of cuprophan and polyacrylonitrile membranes.
    Stefanovic V; Vlahovic P; Kostic S; Mitić-Zlatkovic M
    Nephron; 1998; 79(3):350-1. PubMed ID: 9678440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.